NovaPoint Capital’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26M Buy
35,887
+1,352
+4% +$245K 1.09% 34
2026
Q1
$5.08M Buy
34,535
+1,023
+3% +$166K 1.27% 32
2025
Q4
$6.53M Buy
33,512
+1,682
+5% +$400K 1.68% 20
2025
Q3
$8.95M Buy
31,830
+1,092
+4% +$278K 2.19% 13
2025
Q2
$6.72M Buy
30,738
+1,631
+6% +$263K 2.06% 12
2025
Q1
$4.07M Buy
29,107
+1,304
+5% +$212K 1.25% 29
2024
Q4
$4.63M Buy
27,803
+991
+4% +$176K 1.41% 23
2024
Q3
$4.57M Buy
26,812
+904
+3% +$131K 1.42% 21
2024
Q2
$3.66M Buy
25,908
+1,298
+5% +$161K 1.24% 30
2024
Q1
$3.09M Buy
24,610
+73
+0.3% +$8.36K 1.08% 35
2023
Q4
$2.59M Buy
+24,537
New +$2.68M 0.96% 43

Other funds holding ORCL

NovaPoint Capital's ORCL Position: Q2 2026 in Review

NovaPoint Capital increased its Oracle (ORCL) stake by 3.9% in Q2 2026, buying an estimated $245K and bringing the position to 35,887 shares worth $5.26M. The position accounts for 1.09% of the portfolio, ranked #34.

NovaPoint Capital first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.95M in Q3 2025. 3,513 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • NovaPoint Capital held 35,887 shares of Oracle worth $5.26M as of Q2 2026.
  • NovaPoint Capital bought 1,352 Oracle shares in Q2 2026, an estimated $245K.
  • Oracle made up 1.09% of NovaPoint Capital's portfolio in Q2 2026, its #34 holding.
  • NovaPoint Capital first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • NovaPoint Capital's Oracle position peaked at $8.95M in Q3 2025.
  • 3,513 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.